Insider · CIK 0001953094
James P Boylan
director
Files at IMNM (Immunome Inc.), CAMP (Camp4 Therapeutics Corp), CMPX (Compass Therapeutics, Inc.), ZBIO (Zenas BioPharma, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | CAMP Camp4 Therapeutics Corp | AGrant or award Stock Option (Right to Buy)derivative | +9,000 | $0.00 | $0 | 9,000 | Jun 27, 2025 |
| Jun 10, 2025 | ZBIO Zenas BioPharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +18,500 | $0.00 | $0 | 18,500 | Jun 12, 2025 |
| Jun 10, 2025 | IMNM Immunome Inc. | AGrant or award Director Stock Option (right to buy)derivative | +18,864 | $0.00 | $0 | 18,864 | Jun 12, 2025 |
| Feb 11, 2025 | CMPX Compass Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Feb 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.